Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.

about

Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.

Item

http://www.wikidata.org/entity/Q51779979

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Retrospective evaluation of to ...... tic appendicular osteosarcoma.

@en

Retrospective evaluation of toceranib

@nl

type

Item

label

Retrospective evaluation of to ...... tic appendicular osteosarcoma.

@en

Retrospective evaluation of toceranib

@nl

prefLabel

Retrospective evaluation of to ...... tic appendicular osteosarcoma.

@en

Retrospective evaluation of toceranib

@nl

P1476

Retrospective evaluation of to ...... tic appendicular osteosarcoma.

@en

P2093

Anthony J Mutsaers

http://www.w3.org/2001/XMLSchema#string

Arata Matsuyama

http://www.w3.org/2001/XMLSchema#string

Changseok Kim

http://www.w3.org/2001/XMLSchema#string

J Paul Woods

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Isolation of putative progenitor endothelial cells for angiogenesis

Molecular mechanisms and clinical applications of angiogenesis

Role of angiogenesis in tumor growth and metastasis

Basic and therapeutic aspects of angiogenesis

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program

Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program.

P304

1059-1064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28966355

http://www.w3.org/2001/XMLSchema#string

P932

5603930

http://www.w3.org/2001/XMLSchema#string